Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance - Wikidata - wikimedia - TriplyDB

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

http://www.wikidata.org/entity/Q24813854

about

Biomarkers in triple negative breast cancer: A review Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinoma Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo.COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer.Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer.Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients.Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin COX-2 expression and tumor angiogenesis in thyroid carcinoma patients among northeast Chinese population-result of a single-center study.Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness.Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.Cyclooxygenase-2 expression in animal cancers.Potency of non-steroidal anti-inflammatory drugs in chemotherapy.Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway.Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.Multidrug resistance in breast cancer: from in vitro models to clinical studies.Cox-2 and its association with prognostic factors and response to primary chemotherapy in patients with breast cancer.Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines.The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways.Pilot study: duodenal MDR1 and COX2 gene expression in cats with inflammatory bowel disease and low-grade alimentary lymphoma.Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67.The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo

P2860

Q26775094-4F96B62E-6A57-48A2-9FCF-3D894A145FD3 Q28543497-1B662DC2-30E1-4C68-8B58-98FB04ACCEFE Q33733037-58344353-1210-408E-81AE-EFB172B81E41 Q33747000-E29CEBAC-2429-45FD-B051-4B88C1F5CCF7 Q33821114-47E80D04-1F41-4B23-843A-9F35F55F65EB Q34165529-8F0F2C8E-2A19-4E1E-A262-C2178C1AD3A2 Q34316720-FA76C8FC-FA32-404F-8298-152AB794A848 Q34755674-52D4C3C5-AD31-491B-A88A-5B07DC7F90E5 Q35056229-E3D6C6CC-C75C-48C5-A4A4-C40389655D91 Q35108403-904D14D2-F29A-40B2-90C5-BDBC9811CBF0 Q35797114-5E6858A3-40D0-4542-9DDF-B341D69E0488 Q35947551-C46E3996-21EB-448E-8260-04815D587558 Q36458788-2F43D753-3CC9-4897-932F-55868FEE610F Q36483712-3B9724B1-5FFD-425D-A445-6185A529B8B6 Q36613823-A184B20A-24CC-4243-892C-F5F9916CE44C Q36923104-C810555E-2E39-46B6-96B7-EED9BEF0B22D Q37229340-A510A8D7-2A0B-480A-AA1A-56452E3A635F Q37405065-4750DDAA-C31B-4036-A340-79098A210C5D Q37701526-762391CB-7E0E-434F-8401-6301E9912292 Q37793667-180AB2D6-6BE4-41A2-B17C-C1E1276F71E5 Q38282100-7FBEF393-E2C3-469B-B445-957697B8FBE0 Q38722912-50EAE3D3-95E9-4675-95B0-E0B6C1854340 Q39384371-DF848CDD-A8E8-4743-B9CA-3EFF29C70D39 Q42695791-2B46BB15-6193-4F4D-88E7-B223400A7DB0 Q42772527-02BB2928-A0CC-4CA3-A4EC-5FBE4D5C38B2 Q43007158-C89E8FCB-DE18-446C-8FCF-EBAA1438CF50 Q47273449-4EDCE0E8-B1E9-4214-876F-07E61337B314 Q47289144-B6AC42AC-5BBC-4DBC-8ED1-B02586FCFEC2 Q47742647-044462F6-7C56-4A39-89DB-4345FB642CC1 Q47977198-FAC3D751-0B78-41BE-AB55-7DD9B8DDDB31 Q58718462-911B5A43-BBDC-4388-B243-4458F8A6EC7B

P2860

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

http://www.wikidata.org/entity/Q24813854

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Relationship between the expre ...... their prognostic significance

@ast

Relationship between the expre ...... their prognostic significance

@en

Relationship between the expre ...... their prognostic significance

@nl

type

label

Relationship between the expre ...... their prognostic significance

@ast

Relationship between the expre ...... their prognostic significance

@en

Relationship between the expre ...... their prognostic significance

@nl

prefLabel

Relationship between the expre ...... their prognostic significance

@ast

Relationship between the expre ...... their prognostic significance

@en

Relationship between the expre ...... their prognostic significance

@nl

P1433

Q24813854-E8F67F4D-BE04-49FE-BF8E-2A7D362AC907

P1476

Q24813854-4412E31F-05DF-4076-A2CE-A50BFCC44E73

P2093

Q24813854-0902CAED-C077-4CD3-A1E9-4890489804A9

Q24813854-45090C00-B655-4C15-AEBA-7A6AB82FD775

Q24813854-4E5770A8-5065-4C5A-A704-FA82C17E86D0

Q24813854-802F8308-12E9-4C3F-8E8E-02961A11AA19

Q24813854-809BC88A-90C7-408F-80C7-0567B095470D

Q24813854-8C6B7155-B381-4586-9D12-5B9AE94184F5

Q24813854-93AEAD31-E297-47E3-80DC-42E5F02D2341

Q24813854-962306ED-B6DC-49B2-BAA7-30ECA0DFE904

P2860

Q24813854-1185CA9F-88CC-4974-AAC4-F83A31463A92

Q24813854-1A1946B4-0D54-4AF0-8326-DC4A8EBCF9D1

Q24813854-1A340DE0-1732-4288-9221-B7EB3095B190

Q24813854-1C2243A1-4B8C-40A5-9F4D-59099D42A60C

Q24813854-242DDE8F-8998-4A7F-A719-E5F7DBAF904D

Q24813854-337D76BB-0BA5-4924-A91C-B8AA7CBD1955

Q24813854-398677F4-A1E8-4A42-BBDB-229E2482E6A7

Q24813854-39B3D410-B98E-4550-8871-023ACC213782

Q24813854-3B281800-B1B1-4A06-9965-D304DBF219CA

Q24813854-3CB45041-D828-48C4-BC71-FC44361EB135

P2888

Q24813854-B28E06C4-B403-4CEC-A892-148E1283265B

P304

Q24813854-C3464AF9-1A12-4EB4-A863-B99CD0A3B94D

P31

Q24813854-859CFE94-EDB0-4B97-BAEA-481569AEC2D5

P356

Q24813854-BA0CC686-EADB-4760-928F-EF094735CEC0

P407

Q24813854-F1BA30B9-C6FE-475B-80FE-062F852E2E2B

P433

Q24813854-EDA93C0E-7DB4-4270-932C-6C989E743572

P478

Q24813854-1B85378D-5F67-45BF-ACD3-D567ACAA17AD

P50

Q24813854-1B14FACC-7F9D-4FF9-81F6-6CB9CFD64323

Q24813854-2E4649F7-E6A9-49C2-8EBD-C66BDF8BB42C

Q24813854-94A3E3B9-C05F-4595-999E-37E13BC9A42D

P577

Q24813854-4F012DB6-DB40-4759-B58E-A2F50272A522

P5875

Q24813854-959BBE30-6D36-426B-BBBA-7A25E0831CC2

P6179

Q24813854-3DBABC1C-9561-4C89-B1BA-1EE44154B2C8

P698

Q24813854-0B20399A-5E10-4D49-9C0C-219CF82E694B

P932

Q24813854-33AB9492-A56F-4B31-B88E-A5FF40C94C14

P356

P1433

Breast Cancer Research

P1476

Relationship between the expre ...... their prognostic significance

@en

P2093

Andrzej Wojnar

http://www.w3.org/2001/XMLSchema#string

Hermann Lage

http://www.w3.org/2001/XMLSchema#string

Jan Kornafel

http://www.w3.org/2001/XMLSchema#string

Katarzyna Szczuraszek

http://www.w3.org/2001/XMLSchema#string

Maciej Zabel

http://www.w3.org/2001/XMLSchema#string

Marek Pudelko

http://www.w3.org/2001/XMLSchema#string

Rafal Matkowski

http://www.w3.org/2001/XMLSchema#string

Verena Materna

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention

Multidrug resistance in cancer: role of ATP-dependent transporters

Cancer statistics, 2002

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

Expression of cyclooxygenase 2 in human malignant melanoma.

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

Predictive and prognostic markers for invasive breast cancer.

ABC-transporters: implications on drug resistance from microorganisms to human cancers.

P2888

P304

R862-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR1313

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Carsten Denkert

P577

2005-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7595856

http://www.w3.org/2001/XMLSchema#string

P6179

1014635869

http://www.w3.org/2001/XMLSchema#string

P698

16168133

http://www.w3.org/2001/XMLSchema#string

P932

1242165

http://www.w3.org/2001/XMLSchema#string